Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical: A Fairly Valued Medtech Benefiting From A Steadily Growing Robotic Surgery Market

Amazon

Alphabet

These stocks should be sitting pretty when the COVID-19 pandemic is in the rearview mirror.

3 Great Stocks You Can Buy to Profit in a Post-Coronavirus World

Adobe

Visa

These financial rock stars are built to last.

3 Stocks You Can Set and Forget

Mastercard

Exxon Mobil

A plunging stock market is your opportunity to buy great businesses at a discount.

5 Smart Stocks to Buy During a Stock Market Crash

“Elective” surgeries can only be delayed for so long.

Intuitive Surgical's Coronavirus Slump Is Likely to Be Brief

The company's shares gained about half a percentage point following its quarterly update.

Intuitive Surgical Posts Solid Results, but the Future Is Hazy

Medtronic

Veeva Systems

These industry leaders will emerge from the coronavirus pandemic stronger than ever.

3 Best Healthcare Stocks to Buy for the Next Decade

Intuitive Surgical (ISRG) first-quarter results benefit from strong growth across all businesses and higher revenues.

Intuitive Surgical (ISRG) Q1 Earnings Beat Estimates, Up Y/Y

Intuitive Surgical, Inc (ISRG) CEO Gary Guthart on Q1 2020 Results - Earnings Call Transcript

Shares of Intuitive Surgical inched up late Thursday after the robotic surgery giant beat first-quarter sales and earnings expectations. But the company didn't issue guidance for 2020.

Robotic Surgery Giant Edges Up On First-Quarter Earnings Beat

Despite a recent rally, the stock market could plunge again. Here are two stocks to buy no matter what happens.

Coronavirus Market Crash: Is the Worst Yet to Come?

Intuitive Surgical's (ISRG) Q1 earnings are likely to reflect better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth.

What's in Store for Intuitive Surgical (ISRG) Q1 Earnings?

Bristol-Myers

Western Digital

The answer really depends on your investment time horizon.

Growth Stocks vs. Value Stocks: Which Should You Buy?

American Eagle Outfitters

Livongo Health Inc

Pinterest

Block

Bear markets have always represented an excellent time for investors to go shopping.

10 Brand-New Stocks I Bought During the Stock Market Crash

Eli Lilly

The high-growth healthcare sector is a smart place to put your money to work during the COVID-19 pandemic. Just be careful what stocks you buy.

2 Top Healthcare Stocks to Buy and 1 to Avoid During the Coronavirus Crash

The robotic surgery pioneer is a healthcare disruptor set to deliver market-beating returns over the next decade.

Here's Why Intuitive Surgical is the Tesla of the Healthcare Industry

Sirius XM Holdings Inc

Wheaton Precious Metals

This could be the opportunity of a generation to buy into four great companies at a discount.

Got $2,500? Park It in These 4 Stocks for the Next 20 Years

Intuitive Surgical, Inc. (NASDAQ: ISRG) shares are trading lower on Thursday, after the company withdrew its fiscal year 2020 guidance due to the coronavirus (COVID-19).

Why Intuitive Surgical's Stock Is Trading Lower Today

MongoDB

They're beaten down because of the coronavirus crisis. But both of these stocks should roar back.

If You Have $2,000 to Invest, Here Are 2 Great Stocks to Buy Right Now

Significantly fewer procedures are now being done using its robotic surgical systems, and hospitals are postponing installation of new systems.

Intuitive Surgical Reports Significant COVID-19 Impact in Q1, Withdraws 2020 Guidance

AT&T

Brand-name businesses with clear-cut competitive advantages are a great place to park your money for the long haul.

Smart Investors With $1,000 Are Buying These Stocks Right Now

Microsoft

Netflix

If you have disposable cash, buying into these emerging trends looks like a smart move for the next two decades.

3 Stocks to  Hold for the  Next 20 Years

Intuitive Surgical Is An Attractive Opportunity For Patient Investors

Innovative Industrial Properties

Palo Alto Networks

The coronavirus crash has created an attractive entry point for these five fast-growing businesses.

Got $2,500? Here Are 5 High-Growth Stocks to Buy Now

Based on historical performance, Intuitive Surgical appears to be an attractive bet compared to Boston Scientific in the current crisis. The current coronavirus crisis will likely impact medical devices companies on two fronts, 1.

News for Intuitive Surgical Stock (ISRG)